Filing Details
- Accession Number:
- 0001181431-12-031766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-22 19:21:58
- Reporting Period:
- 2012-05-18
- Filing Date:
- 2012-05-22
- Accepted Time:
- 2012-05-22 18:21:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1323885 | Atricure Inc. | ATRC | Surgical & Medical Instruments & Apparatus (3841) | 341940305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1336087 | J David Drachman | 6217 Centre Park Drive West Chester OH 45069 | President, Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-18 | 5,343 | $1.33 | 497,609 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-18 | 5,343 | $8.19 | 492,266 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-05-22 | 33,841 | $8.24 | 458,425 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-18 | 5,343 | $0.00 | 5,343 | $1.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,553 | 2003-10-14 | 2012-10-14 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $8.10 to $8.29 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The Reporting Person intends to apply proceeds from the disposition of these shares to the payment of taxes and other costs incurred in connection with the exercise of options reported separately.
- This transaction was executed in multiple trades at prices ranging from $8.20 to $8.40 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).